BCL2L1 and melanoma: During the preparation of the final version of this manuscript, TIS melanoma cells were found to share a BCL-xL-mediated pro-survival adaptation underlying the exquisite senolytic activity of A1331852 and the PROTAC BCL-xL degrader DT2216 [93].